Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

Share Price is delayed by 15 minutes
Get Live Data
5,965.00    -50.00 (-0.83%)
Bid:
5,960.00
Ask:
5,965.00
Spread: 5.00 (0.084%)
Market Cap: £5.10b
DCC Live PriceLast checked at - London Stock Exchange

Intraday DCC Share Chart

Interim Management Statement

13 Jul 2018 07:00

RNS Number : 5588U
DCC PLC
13 July 2018
 

 

 

 

13 July 2018

 

DCC plc

 

Interim Management Statement

 

Strong Growth in First Quarter Operating Profit and Guidance for the Year Reiterated

 

DCC plc, the leading international sales, marketing and support services group, is issuing this Interim Management Statement in advance of the Company's AGM to be held in Dublin at 11.00 am today.

 

First quarter ended 30 June 2018

Group operating profit for the first quarter ended 30 June 2018 was in line with expectations and, as anticipated, well ahead of the prior year, driven by acquisitions completed in the prior year.

 

Year ending 31 March 2019

DCC's profits are significantly weighted towards the second half of its financial year. At what is still a very early stage in the financial year, the Group reiterates its belief that the year ending 31 March 2019 will be another year of profit growth and development.

 

Development activity

DCC has today separately announced that DCC Technology has acquired Stampede in the US and Kondor in the UK.

 

Stampede is a specialist distributor of professional audio-visual products and solutions to system integrators, value-added resellers, retailers and etailers in the US, Canada and the UK. Stampede recorded revenue of $280 million in the year ended 31 December 2017 and employs approximately 210 people. The acquisition of Stampede represents DCC Technology's first acquisition in North America and is consistent with DCC Technology's strategy to extend the geographic footprint and product range of its successful and growing professional audio-visual business, strengthening its partnership with existing suppliers, while also broadening its base of customers and suppliers.

 

Kondor distributes mobile and accessory products and provides outsourced category management solutions to the retail channel in the UK and Continental Europe. Kondor recorded revenue of £110 million in the year ended 31 December 2017 and employs approximately 250 people. The acquisition of Kondor strengthens DCC Technology's position as one of the leading omnichannel distribution and supply chain businesses in Europe.

 

The combined initial enterprise value of Stampede and Kondor is c.£110 million. DCC expects the acquisitions to generate a return on capital employed of approximately 15% in the first full year of ownership.

 

DCC has grown substantially in recent years and now has significant operations across 17 countries, with market-leading positions in each of its LPG, Retail & Oil, Healthcare and Technology divisions. DCC's ambition and capacity for further development, together with the Group's leading market positions and increased geographic reach, provide substantial opportunity for the continued growth and development of the business.

 

Forthcoming events

DCC will host a Capital Markets Day for analysts and institutional investors in Marseille, France on Thursday 13 September 2018.

 

DCC expects to announce its interim results for the six months to 30 September 2018 on Tuesday 13 November 2018.

 

For reference:

Donal Murphy, Chief Executive

Fergal O'Dwyer, Chief Financial Officer

Kevin Lucey, Head of Capital Markets

 

Telephone: +353 1 2799 400

Email: investorrelations@dcc.ie

Web: www.dcc.ie

 

Powerscourt (Media)

Lisa Kavanagh / Victoria Palmer-Moore

Telephone: +44 20 7250 1446

Email: DCC@powerscourtgroup.com

 

 

 

About DCC plc

DCC is a leading international sales, marketing and support services group with a clear focus on performance and growth. It operates through four divisions: LPG, Retail & Oil, Healthcare and Technology.

 

DCC is an ambitious and entrepreneurial business operating in 17 countries, supplying products and services used by millions of people every day throughout Europe. Building strong routes to market, driving for results, focusing on cash conversion and generating superior sustainable returns on capital employed enable the Group to reinvest in its business, creating value for its stakeholders.

 

Headquartered in Dublin, employing approximately 11,000 people, DCC's four divisions are:

· DCC LPG - a leading LPG sales and marketing business with operations in Europe, Asia and the US and a developing business in the retailing of natural gas and electricity;

· DCC Retail & Oil - a leader in the sales, marketing and retailing of transport and commercial fuels, heating oils and related products and services in Europe;

· DCC Healthcare - a leading healthcare business, providing products and services to healthcare providers and health and beauty brand owners; and

· DCC Technology - a leading sales, marketing and services partner for global technology brands.

 

DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100. In its financial year ended 31 March 2018, DCC generated revenue of £14.3 billion and operating profit of £383.4 million.

 

DCC has an excellent record, delivering compound annual growth of 14.4% in operating profit and generating an average return on capital employed of approximately 19% over 24 years as a public company.

 

Forward-looking statements

This announcement contains some forward-looking statements that represent DCC's expectations for its business, based on current expectations about future events, which by their nature involve risk and uncertainty. DCC believes that its expectations and assumptions with respect to these forward-looking statements are reasonable, however because they involve risk and uncertainty as to future circumstances, which are in many cases beyond DCC's control, actual results or performance may differ materially from those expressed in or implied by such forward-looking statements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTEXLBFVDFZBBK
Date   Source Headline
22nd Sep 20204:29 pmRNSHolding in Company TR-1
21st Sep 20207:00 amRNSDCC expands LPG business in the US and Netherlands
9th Sep 20203:18 pmRNSAppointment of General Counsel & Company Secretary
4th Sep 20204:10 pmRNSUpdate on LTIP Performance Condition Ranges
31st Jul 202012:52 pmRNSTotal Voting Rights
23rd Jul 20204:14 pmRNSHolding in Company TR-1
21st Jul 202011:42 amRNSDirector/PDMR Shareholding
20th Jul 20204:00 pmRNSHolding in Company TR-1
17th Jul 20201:59 pmRNSResult of AGM
17th Jul 20207:00 amRNSInterim Management Statement
14th Jul 20202:28 pmRNSHolding in Company TR-1
8th Jul 202011:38 amRNSHolding in Company TR-1
24th Jun 20209:39 amRNSHolding in Company TR-1
18th Jun 202012:25 pmRNS2020 Annual Report, Notice of AGM and Proxy Form
3rd Jun 202010:10 amRNSHolding in Company TR-1
29th May 202011:27 amRNSTotal Voting Rights
28th May 20206:21 pmRNSDirector/PDMR Shareholding
28th May 20201:02 pmRNSHolding in Company TR-1
19th May 20205:04 pmRNSBoard Changes
19th May 20207:00 amRNSResults for the year ended 31 March 2020
14th May 20203:30 pmRNSHolding in Company TR-1
27th Apr 20206:02 pmRNSDisclosure of Rights Attached to Equity Shares
16th Apr 20204:24 pmRNSDirector Declaration
9th Apr 20204:21 pmRNSHolding in Company TR-1
3rd Apr 20204:01 pmRNSHolding in Company TR-1
25th Mar 20203:22 pmRNSHolding in Company TR-1
25th Mar 20207:00 amRNSDCC Healthcare announces acquisition of Amerilab
19th Mar 20204:10 pmRNSHolding in Company TR-1
19th Mar 20209:46 amRNSHolding in Company TR-1
18th Mar 202012:14 pmRNSHolding in Company TR-1
6th Mar 20204:08 pmRNSHolding in Company TR-1
28th Feb 202010:54 amRNSTotal Voting Rights
24th Feb 20208:38 amRNSBoard Change
24th Feb 20208:34 amRNSChief Financial Officer Succession
12th Feb 20209:10 amRNSHolding in Company TR-1
4th Feb 20207:00 amRNSInterim Management Statement
17th Jan 20209:23 amRNSHolding in Company TR-1
3rd Jan 202010:03 amRNSHolding in Company - TR1
23rd Dec 201912:44 pmRNSHolding in Company TR-1
5th Dec 20195:44 pmRNSHolding in Company - TR1
29th Nov 20191:39 pmRNSTotal Voting Rights
27th Nov 20199:18 amRNSDirector Declaration
18th Nov 20196:14 pmRNSDirector/PDMR Shareholding
12th Nov 20197:00 amRNSResults for the six months ended 30 September 2019
12th Nov 20197:00 amRNSDCC Healthcare acquires Ion Laboratories
7th Nov 201911:30 amRNSHolding in Company TR-1
23rd Oct 20192:25 pmRNSHolding in Company TR-1
21st Oct 20195:01 pmRNSHolding in Company TR-1
18th Oct 20194:46 pmRNSHolding in Company TR-1
17th Oct 20199:43 amRNSHolding in Company TR-1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.